Drug implants offer an alternative for controlling drug release and maintaining plasma levels of a specific drug. In this study, we explored the potential of imidazolium methacrylate crosslinking with resorcinol methacrylate to develop implantable drug delivery systems. The focus was on fabricating a photopolymerizable material based on a novel biocompatible hydrogel for implantable drug delivery systems with dexamethasone, a widely used corticosteroid with potent anti‐inflammatory properties, chosen as the model drug. The experimental section detailed the synthesis of polymerizable units, resin preparation, and resin choice for further tests using a 23 factorial design, printing conditions, material characterization, biocompatibility, and dexamethasone release tests. Our findings shed light on the potential of this novel approach for creating targeted drug delivery systems, holding promise for improving therapeutic outcomes, and reducing side effects associated with systemic long‐term drug administration.